临床和遗传特征在淋巴瘤患者的第二个固体恶性瘤
Di Zhou1, Leng Han1, Chanjuan Jin1
1Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Frontiers in oncology
|August 7, 2023
概括
多种原发性恶性瘤,包括淋巴瘤和固体瘤,存在诊断挑战. 芬科尼贫血补充组 (FANC) 基因中的生殖系突变可能使患者易患这些复杂癌症.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 临床医学 临床医学
背景情况:
- 多重原发性恶性瘤 (MPMs) 带来了越来越多的临床挑战.
- 与固体瘤同时发生的淋巴瘤需要进一步的临床和遗传特征.
研究的目的:
- 研究患有淋巴瘤和其他固体瘤的患者的临床和遗传特征.
- 为了确定潜在的遗传倾向发展MPMs.
主要方法:
- 对11名淋巴瘤和固体瘤患者的回顾性分析.
- 针对性下一代细菌和体质突变的测序.
- 临床数据和治疗结果的分析.
主要成果:
- 结肠腺癌和乳头甲状腺癌是最常见的同时发生的固体瘤.
- 对于同步病例和超时病例均观察到有效的治疗策略.
- 一个重要的发现是Fanconi贫血补充组 (FANC) 基因中生殖基因突变的高患病率 (10/11).
结论:
- 了解MPM的临床和遗传情景对于改善诊断和治疗至关重要.
- 生殖系FANC基因突变可能表明淋巴瘤患者患有第二种固体恶性瘤的倾向.
更多相关视频
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
21.2K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.6K
相关概念视频
Secondary Lymphoid Organs
1.6K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
1.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
